TITLE

Drug safety in Canada: 2 steps forward, 1 step back

AUTHOR(S)
Orser, Beverley A.; Dionee, Claire; Hyland, Sylvia
PUB. DATE
January 2006
SOURCE
CMAJ: Canadian Medical Association Journal;1/3/2006, Vol. 174 Issue 1, p66
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented commenting on the label of AstraZeneca's bupivacaine drug.
ACCESSION #
19229261

 

Related Articles

  • Literacy Medication Labels. Zargarzadeh, Amir H.; Law, Anandi V. // JGIM: Journal of General Internal Medicine;Jun2009, Vol. 24 Issue 6, p779 

    A letter to the editor is presented in response to the article "Improving patient understanding of prescription drug label instructions" in one of the previous issues.

  • FDA Drug Information That Never Reaches Clinicians. Cook, G. Elliott; Sasich, Larry D.; Sukkari, Sana R. // New England Journal of Medicine;2/11/2010, Vol. 362 Issue 6, p561 

    A letter to the editor is presented in response to the article "Lost in Transmission-FDA drug information that never reaches clinicians," by L. M. Schwartz and S. Woloshin in the October 29, 2009 issue.

  • FDA Drug Information That Never Reaches Clinicians. Woloshin, Steven; Schwartz, Lisa M. // New England Journal of Medicine;2/11/2010, Vol. 362 Issue 6, p561 

    A response by Steven Woloshin and Lisa M. Schwartz to a letter to the editor about their article "Lost in Transmission-FDA drug information that never reaches clinicians" in the October 29, 2009 issue is presented.

  • Durg Nmae Cnofsiuon or Drug Name Confusion?  // Journal of Pharmacy Practice & Research;2009, Vol. 39 Issue 3, p246 

    A letter to the editor is presented regarding the contribution of drug name confusion on medication incidents.

  • Look alike drug labels : A worrying issue. Arora, Vikramjeet; Bajwa, Sukhminder Jit Singh; Kaur, Jasbir // Indian Journal of Anaesthesia;Jul/Aug2011, Vol. 55 Issue 4, p428 

    A letter to the editor is presented in response to the article concerning the disastrous problem of look-alike drugs.

  • Letter to the Editor. Lebwohl, Mark // Dermatology Times;May2005, Vol. 26 Issue 5, p5 

    A letter to the editor is presented in response to the decision of the U.S. Food and Drug Administration to add black box warning to the labels of two new eczema drugs.

  • To The Editor. Thrasybule, Linda // FDA Consumer;Sep2004, Vol. 38 Issue 5, p2 

    Presents a letter to the editor about the difficulty of reading drug labels.

  • Student pharmacists: Don't forget the product labeling. Minor, Paul Donaldson; Cook, G. Elliott // Journal of the American Pharmacists Association: JAPhA;Nov/Dec2008, Vol. 48 Issue 6, p696 

    A letter to the editor is presented about the responsibility of pharmacists to gain awareness on product labeling.

  • Drug safety in Canada: 2 steps forward, 1 step back. Feltmate, Karen // CMAJ: Canadian Medical Association Journal;1/3/2006, Vol. 174 Issue 1, p66 

    A response by AstraZeneca to a letter to the editor about the label of its bupivacaine drug is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics